Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.
The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.
Comments closedHealth Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.
The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.
Comments closedThe U.S. Centers for Disease Control and Prevention director on Tuesday signed off on broad use of updated COVID-19 vaccines approved by the government – covering ages 6 months and up – as the country prepares to start a vaccination campaign within days.
Comments closedHealth Canada has approved Moderna’s updated COVID-19 vaccine for all Canadians who are six months of age and older — while two other options for fall shots remain in the regulatory pipeline.
Comments closedPfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA.2.86 subvariant of the coronavirus in a preclinical study in mice.
Comments closedHealth Canada is currently reviewing applications for Moderna and Pfizer-BioNTech’s new mRNA vaccines, developed against the dominant XBB.1.5 variant ahead of a vaccination campaign set for the fall.
Comments closedCovid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.
Comments closed